{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:44:18Z","timestamp":1776876258073,"version":"3.51.2"},"reference-count":36,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2025.2474886","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:27:16Z","timestamp":1741321636000},"page":"436-444","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-5341","authenticated-orcid":false,"given":"Juan E.","family":"Megias-Vericat","sequence":"first","affiliation":[{"name":"Hospital Universitario y Polit\u00e9cnico La Fe","place":["Valencia, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-0381","authenticated-orcid":false,"given":"Gines","family":"Escolar","sequence":"additional","affiliation":[{"name":"Hematopathology, Department of Pathology, Centre de Diagnostic Biomedic (CDB), Hospital Clinic de Barcelona, Institut d\u2019Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-4192","authenticated-orcid":false,"given":"Michele R.","family":"Wilson","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4907-802X","authenticated-orcid":false,"given":"Pablo","family":"Mendez","sequence":"additional","affiliation":[{"name":"CSL Behring S.p.A","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-8955","authenticated-orcid":false,"given":"Cheryl L.","family":"McDade","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Vidal","family":"Barrientos","sequence":"additional","affiliation":[{"name":"CSL Behring S.p.A","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Tomic","sequence":"additional","affiliation":[{"name":"CSL Behring S.p.A","place":["Milan, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Panebianco","sequence":"additional","affiliation":[{"name":"CSL Behring S.p.A","place":["Milan, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-1799","authenticated-orcid":false,"given":"Stephan","family":"Linden","sequence":"additional","affiliation":[{"name":"CSL Behring S.p.A","place":["Barcelona, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-3839","authenticated-orcid":false,"given":"Songkai","family":"Yan","sequence":"additional","affiliation":[{"name":"CSL Behring","place":["King of Prussia, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.21037\/aob.2017.12.08"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003265"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20327"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12589"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12589"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10327"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221120583"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01901.x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000568"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2006.01.021"},{"issue":"5","key":"e_1_3_4_12_1","first-page":"391","article-title":"A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF\/FVIII concentrates in severe inherited von Willebrand disease","volume":"17","author":"Peyvandi F","year":"2019","unstructured":"Peyvandi F, Castaman G, Gresele P, et\u00a0al. A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF\/FVIII concentrates in severe inherited von Willebrand disease. Blood Transfus. 2019;17(5):391.","journal-title":"Blood Transfus"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003264"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136241"},{"key":"e_1_3_4_15_1","unstructured":"Rind DM Walton SM Agboola F Institute for Clinical and Economic Review (ICER) et\u00a0al. Valoctocogene roxaparvovec and emicizumab for hemophilia A: effectiveness and value. Final Report. 2020."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000679"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.19406"},{"key":"e_1_3_4_18_1","volume-title":"Gu\u00eda y recomendaciones para la realizaci\u00f3n y presentaci\u00f3n de evaluaciones econ\u00f3micas y an\u00e1lisis de impacto presupuestario de medicamentos en el \u00e1mbito del CatSalut","author":"de la Salut SC.","year":"2014","unstructured":"de la Salut SC. Gu\u00eda y recomendaciones para la realizaci\u00f3n y presentaci\u00f3n de evaluaciones econ\u00f3micas y an\u00e1lisis de impacto presupuestario de medicamentos en el \u00e1mbito del CatSalut. Barcelona: Generalitat de Catalunya, Departament de Salut, CatSalut; 2014."},{"key":"e_1_3_4_19_1","unstructured":"CSL-B data on file. Evidence synthesis in the treatment of von Willebrand disease. Systematic literature review and pooled analysis. 2021."},{"key":"e_1_3_4_20_1","unstructured":"Instituto Nacional Estad\u00edstica (INE). Population by gender. 2022."},{"key":"e_1_3_4_21_1","unstructured":"eSalud. Encuesta Nacional de Salud. 2021."},{"key":"e_1_3_4_22_1","unstructured":"Bot PLUS. Base de Datos de medicamentos del Consejo General de Farmac\u00e9uticos (Bot PLUS. 2.0). 2022."},{"key":"e_1_3_4_23_1","unstructured":"Wilate S. Wilate Summary Product Characteristics (SmPC). 2020."},{"key":"e_1_3_4_24_1","unstructured":"Haemate PS. Haemate-P Summary Product Characteristics (SmPC). 2015."},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000257"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.029868"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12621"},{"key":"e_1_3_4_28_1","unstructured":"Fanhdi S. Fanhdi Summary Product Characteristics (SmPC). 2018."},{"key":"e_1_3_4_29_1","unstructured":"Oblikue. Oblikue Consulting. eSalud\u2014Informaci\u00f3n econ\u00f3mica del sector sanitario. 2022."},{"key":"e_1_3_4_30_1","unstructured":"CMBD. Gobierno de Expana. Ministerio de Sanidad. Portal Estad\u00edstico. \u00c1rea de Inteligencia de Gesti\u00f3n. El Registro de Actividad Sanitaria Especializada (RAE-CMBD). 2020."},{"key":"e_1_3_4_31_1","volume-title":"Healthcare cost database eSalud","author":"eSalud. Gisbert R","year":"2022","unstructured":"eSalud. Gisbert R, Brosa M. Healthcare cost database eSalud. Barcelona: Oblikue Consulting, SL. Informaci\u00f3n econ\u00f3mica del sector sanitaria. 2022 [Internet]."},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-018-0908-9"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-199311000-00006"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13634"},{"key":"e_1_3_4_35_1","volume-title":"Resultados nacionales, por comunidades aut\u00f3nomas y provincia. Tablas de mortalidad por a\u00f1o, sexo, edad y funciones. Unidades: Personas, %1000, A\u00f1os, A\u00f1os-persona","author":"Instituto Nacional de Estadistica (INE)","year":"2020","unstructured":"Instituto Nacional de Estadistica (INE). Resultados nacionales, por comunidades aut\u00f3nomas y provincia. Tablas de mortalidad por a\u00f1o, sexo, edad y funciones. Unidades: Personas, %1000, A\u00f1os, A\u00f1os-persona. Madrid: Instituto Nacional de Estadistica; 2020."},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S280574"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221130334"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2025.2474886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:59:54Z","timestamp":1776873594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2025.2474886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2025.2474886"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2025.2474886","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}